Inflammation is not the cause of an elevated serum ferritin in non-alcoholic fatty liver disease

被引:28
作者
Beaton, Melanie D. [1 ]
Chakrabarti, Subrata [2 ]
Adams, Paul C. [1 ]
机构
[1] Univ Western Ontario, Dept Med, London, ON N6A 5A5, Canada
[2] Univ Western Ontario, Dept Pathol, London, ON N6A 5A5, Canada
关键词
Non-alcoholic steatohepatitis; Haemochromatosis; Fatty liver; Iron overload;
D O I
10.1016/S1665-2681(19)30864-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. In non-alcoholic fatty liver disease (NALFD), it has often been assumed that an elevation in serum ferritin is likely related to inflammation rather than iron overload. Material and methods. Patients referred with NAFLD were entered into a clinical study of phlebotomy therapy. A liver biopsy with liver iron concentration was done at entry and 6 months after phlebotomy (n = 56) until the patient had a low serum ferritin or developed anemia. Serum ferritin was compared to liver iron concentration, ESR, CRP, BMI and grade of inflammation on liver biopsy. Results. Iron removed by phlebotomy in NAFLD correlated with the decrease in serum ferritin (r = 0.57, p = 0.0014) and liver iron concentration (r = 0.57, p = 0.0013). There was no significant correlations between serum ferritin and ESR, CRP or grade of liver inflammation. Conclusions. Serum ferritin is related to liver iron storage in NAFLD and decreasing body iron stores by phlebotomy is reflected by an appropriate decrease in serum ferritin. Inflammation is not the cause of the elevated serum ferritin in fatty liver disease.
引用
收藏
页码:353 / 356
页数:4
相关论文
共 5 条
[1]   ISOLATION OF A HUMAN HEPATIC FERRITIN RECEPTOR [J].
ADAMS, PC ;
POWELL, LW ;
HALLIDAY, JW .
HEPATOLOGY, 1988, 8 (04) :719-721
[2]   VALUE OF HEPATIC IRON MEASUREMENTS IN EARLY HEMOCHROMATOSIS AND DETERMINATION OF THE CRITICAL IRON LEVEL ASSOCIATED WITH FIBROSIS [J].
BASSETT, ML ;
HALLIDAY, JW ;
POWELL, LW .
HEPATOLOGY, 1986, 6 (01) :24-29
[3]   Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease [J].
Beaton, M. D. ;
Chakrabarti, S. ;
Levstik, M. ;
Speechley, M. ;
Marotta, P. ;
Adams, P. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (07) :720-729
[4]  
Chandok N, 2012, J GASTROINTEST LIVER, V21, P53
[5]   Hyperferritinaemia; laboratory implications [J].
Crook, M. A. .
ANNALS OF CLINICAL BIOCHEMISTRY, 2012, 49 :211-213